Search details
1.
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Br J Haematol
; 198(4): 668-679, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35655410
2.
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.
BMC Cancer
; 21(1): 851, 2021 Jul 23.
Article
in English
| MEDLINE | ID: mdl-34301221
3.
Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.
Haematologica
; 108(5): 1429-1435, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-36519322
4.
Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma.
Br J Haematol
; 196(1): 237-241, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34368952
5.
Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up.
Neuroendocrinology
; 99(2): 108-17, 2014.
Article
in English
| MEDLINE | ID: mdl-24714208
6.
Myeloid Toxicity of Radionuclide Cancer Therapy.
Cancer Biother Radiopharm
; 37(3): 164-172, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34871036
7.
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.
Front Oncol
; 12: 888109, 2022.
Article
in English
| MEDLINE | ID: mdl-35574335
8.
Long-term hematologic toxicity of 177Lu-octreotate-capecitabine-temozolomide therapy of GEPNET.
Endocr Relat Cancer
; 28(7): 521-527, 2021 06 20.
Article
in English
| MEDLINE | ID: mdl-34010146
9.
Efficacy and Haematologic Toxicity of Palliative Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen in Heavily Pre-Treated Patients.
Diagnostics (Basel)
; 11(3)2021 Mar 14.
Article
in English
| MEDLINE | ID: mdl-33799431
10.
Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.
Curr Hematol Malig Rep
; 14(4): 207-218, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31254155
11.
Salvage Radiopeptide Therapy of Advanced Castrate-Resistant Prostate Cancer with Lutetium-177-Labeled Prostate-Specific Membrane Antigen: Efficacy and Safety in Routine Practice.
Cancer Biother Radiopharm
; 33(7): 274-281, 2018 Sep.
Article
in English
| MEDLINE | ID: mdl-29989440
12.
Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.
Diagnostics (Basel)
; 7(2)2017 May 12.
Article
in English
| MEDLINE | ID: mdl-28498337
13.
Myelotoxicity of Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Decade of Experience.
Cancer Biother Radiopharm
; 31(6): 189-98, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27419665
Results
1 -
13
de 13
1
Next >
>>